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Osteopontin expression in human crescentic glomerulonephritis. Osteopontin is a secreted phosphoprotein that has a
Background. Osteopontin is a molecule with diverse biologi- number of diverse biological functions, including cell
cal functions, including cell adhesion, migration, and signaling. adhesion, migration, and signaling. Originally isolated
The expression of osteopontin has been demonstrated in a
from bone, it has been shown to be expressed in a numbernumber of models of renal injury in association with accumula-
of different tissues, including kidney, lung, liver, bladder,tions of monocyte/macrophages, including recent reports of
osteopontin expression in glomerular crescents in a rat model pancreas, and breast [1, 2]. Its expression has also been
of anti-glomerular basement membrane glomerulonephritis. demonstrated in vascular smooth muscle cells and mac-
Methods. Glomerular expression of osteopontin in biopsies rophages in vitro and in vivo [3–6]. Osteopontin has been
of human crescentic glomerulonephritis (N 5 25), IgA nephrop-
shown to be chemotactic for vascular smooth muscle cellsathy with crescents (N 5 2), and diffuse proliferative lupus
in vitro [7] and monocyte/macrophages in vivo [8, 9] andglomerulonephropathy with crescents (N 5 1) was studied by
has been described in a number of models of injury inimmunohistochemistry, in situ hybridization, and combined im-
munohistochemistry/in situ hybridization. Additionally, anti- association with accumulations of macrophages in tissue
bodies to cell-specific phenotypic markers were used to identify [10–15]. In some settings, osteopontin may act as a cell
cellular components of the glomerular crescent, which express survival factor for renal cells [13, 16].
osteopontin protein and mRNA.
These chemotactic and trophic features of osteopontin,Results. All of the crescents present in the biopsies studied
in addition to its up-regulation in the tubulointerstitiumcontained a significant number of cells that expressed osteopon-
in a variety of rodent models of renal injury [11, 12, 14, 15,tin protein and mRNA, demonstrated by immunohistochemis-
try and in situ hybridization, respectively. Using replicate tissue 17–19], suggest that osteopontin could be an important
sections and combined immunohistochemistry/in situ hybrid- mediator of the glomerular injury that occurs in cres-
ization, we showed that the majority of the strongly osteopon- centic glomerulonephritis. It is generally accepted thattin-positive cells are monocyte/macrophages. In addition to the
both monocyte/macrophages and glomerular epithelialvery strong and cell-associated localization, a weaker and more
cells are major components of the cellular crescent. Osteo-diffuse pattern of osteopontin protein and mRNA expression
could be seen in a number of crescents. None of the osteopontin pontin, if present in or near crescents, could contribute
mRNA-expressing cells could be identified as parietal epithe- to the recruitment of monocytes/macrophages in this
lial cells, CD3-positive T cells, or a-smooth muscle actin-posi- process. This hypothesis is considerably strengthened by
tive myofibroblasts. Interstitial monocyte/macrophages did not recent studies in the rat model of anti-glomerular base-express osteopontin, except when located in a periglomerular
ment membrane (GBM) glomerulonephritis; these stud-inflammatory infiltrate.
ies have demonstrated the expression of osteopontin inConclusions. Macrophages present in the human glomerular
crescent express osteopontin protein and mRNA at a high crescentic glomeruli [20]. In this model, osteopontin ap-
level. This expression supports a role for osteopontin in the peared to be expressed predominantly by visceral and
formation and progression of the crescentic lesion via chemo- parietal epithelial cells, and this expression preceded mac-
tactic and signaling properties of the molecule.
rophage influx [20]. Most infiltrating monocytes/macro-
phages had no demonstrable osteopontin expression in
this model. In further studies in the same rat model,Key words: renal injury, anti-glomerular basement membrane glomer-
ulonephritis, monocytes, macrophages, inflammation, crescentic lesion. blocking osteopontin by treating the animals with neu-
tralizing antibody to this molecule resulted in the amelio-Received for publication April 9, 1999
ration of disease [21], indicating the importance of osteo-and in revised form August 8, 1999
Accepted for publication August 29, 1999 pontin for the evolution of the disease process.
We sought to extend these observations in rodents to 2000 by the International Society of Nephrology
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Table 1. Antibodies directed against cell-specific markers
Source and
Antigen Target cell Host Conditions clone or code Reference
Actin Myofibroblasts, smooth muscle cells Mouse No pretreatment Dako 1A4 [28]
Cytokeratins Tubular and parietal epithelial cells Mouse No pretreatment Dako AE1/AE3 [38, 58]
CD3 T cells Rabbit Antigen retrieval Dako A 452 [33, 59]
CD68 Macrophages, monocytes Mouse Antigen retrieval Dako PGM-1 [26]
VCAM (CD106) Parietal epithelial cells Goat Antigen retrieval R & D BBA-19 [34, 35]
HAM56 Macrophages, monocytes, endothelium Mouse Standard ABC Dako HAM56 [27]
P27 Visceral epithelial cells Goat Standard ABC Santa Cruz sc-528G [31]
WT-1 Visceral epithelial cells Rabbit Standard ABC; antigen retrieval Santa Cruz sc-192 [32]
corresponding human disease. We did this by examining osteopontin has been characterized by Western blotting,
the expression of osteopontin mRNA and protein in and its ability to detect osteopontin by immunocytochem-
human renal biopsies demonstrating crescentic glomeru- istry in fixed tissue sections has been previously demon-
lonephritis. In glomeruli involved by crescent formation, strated [5, 23, 24]. Further demonstration of the specific-
we demonstrate that osteopontin is expressed by cells ity of this antibody comes from previous complementary
localized both within areas of the urinary space involved studies that localize expression of osteopontin mRNA
by crescents and within the glomerular tufts. Further to sites of peptide expression in tissue sections [25].
characterization of the cells expressing osteopontin Monocytes/macrophages. PGM1 (Dako, Carpenteria,
mRNA demonstrates that a majority of these cells are CA, USA) is a well-characterized murine monoclonal
monocyte/macrophages. These studies provide clear evi- antibody directed against the CD68 epitope present on
dence that osteopontin is present and may participate human monocytes and macrophages. Its specificity has
in the events of crescentic glomerulonephritis but that been demonstrated by Western blotting, and it has been
important differences in patterns of osteopontin expres- shown to be reactive in formalin-fixed, paraffin-embed-sion may exist between human disease and rodent mod-
ded tissue following antigen retrieval [26].els. These mechanistic differences could limit the appli-
HAM56 (Dako) is a murine monoclonal IgM that iscability of therapeutic approaches targeting osteopontin
reactive with human monocytes and macrophages and alsoderived from animal models of crescentic glomerulone-
demonstrates cross-reactivity with endothelial cells [27].phritis to the treatment of analogous human disease.
a-Smooth muscle actin. 1A4 (Dako) is a murine mono-
clonal antibody specific for a-smooth muscle actin [28].
METHODS It has been extensively characterized by Western blotting
Tissue and has been previously shown to identify smooth muscle
actin in methyl Carnoys and formalin-fixed tissue usingCore needle biopsies were obtained from the Univer-
sity of Washington Medical Center. Biopsies that had immunohistochemical procedures [29, 30].
been diagnosed as crescentic glomerulonephritis (N 5 19), Podocytes. P27 kip1 (p27; Santa Cruz Biotechnology,
IgA nephropathy with crescents (N 5 2), and diffuse prolif- Santa Cruz, CA, USA) is an affinity-purified goat poly-
erative lupus glomerulonephritis with crescents (N 5 1) clonal antibody raised against peptides corresponding to
were studied. As controls, biopsies of diabetic nephropa- amino acids 181 to 298 at the carboxy terminus of human
thy (N 5 2), membranous glomerulonephritis (N 5 2), p27. It has been characterized by Western blotting and
IgA nephropathy without crescents (N 5 5), and proto- immunoprecipitation and has been shown to immunolo-
col transplant biopsies (N 5 6) were used. Additional calize to the nuclei of human podocytes [31].
control tissue consisted of macroscopically normal ap- WT-1 (C-19) is a rabbit polyclonal antibody that reacts
pearing cortex taken from kidneys resected for localized with the Wilms Tumor antigen. It has been characterized
neoplasms (N 5 4). All of the surgical tissue specimens by Western blotting and immunoprecipitation. WT-1 has
were fixed in 10% neutral buffered formalin. In addition, been shown to react with both fetal and adult visceralsix cases of crescentic glomerulonephritis fixed in methyl
epithelial cells [32].Carnoys solution (60% methanol, 30% chloroform, 10%
T cells used in this study were CD3 (Dako), an affinity-acetic acid) were utilized. All fixed tissues were pro-
purified rabbit polyclonal raised against synthetic humancessed and embedded in paraffin according to standard
CD3 peptide. This antibody reacts with the T-lympho-protocols.
cyte–associated CD3 antigen and has been characterized
Antibodies by comparison of cell and tissue immunostaining pat-
terns with other established anti-CD3 antibodies [33].Osteopontin. LF7 is a rabbit polyclonal antibody di-
Parietal epithelial cells. Polyclonal goat anti-vascularrected against the intact osteopontin protein molecule iso-
lated from bone (Table 1) [22]. Its specific recognition of cell adhesion molecule (VCAM; BBA-19; R&D, Minne-
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apolis, MN, USA) has been characterized by Western K (Sigma) in Tris buffer (500 mmol/L NaCl, 10 mmol/L
Tris, pH 8.0) for 30 minutes at 378C. Several 0.5 3 SSCblotting. VCAM has been shown to be widely expressed
on human parietal epithelial cells [34, 35]. washes were followed by prehybridization for two hours
in 50 mL of prehybridization buffer (50% formamide,AE1/AE3. AE1/AE3 (Dako) is a mixture of two
mouse monoclonal IgG1 fractions that is a specific cock- 0.3 mol/L NaCl, 20 mmol/L Tris, pH 8.0, 5 mmol/L ethyl-
enediaminetetraacetic acid, 1 3 Denhardt’s solution,tail pan reactive with human cytokeratins. It reacts with
normal epithelium in a variety of tissues and has been 10% dextran sulfate, 10 mmol/L dithiothreitol, 50 mg/ml
yeast tRNA) at 508C. The hybridizations were startedcharacterized by Western blotting [36, 37]. Cytokeratin
expression has been demonstrated in parietal epithelial by adding 500,000 cpm of 35S-labeled riboprobe in 25 mL
of prehybridization buffer. The hybridization was allowedcells within glomerular crescents [38].
to proceed overnight at 508C. After hybridization, sec-
Immunohistochemistry tions were washed with 0.5 3 SSC, treated with RNase A
(20 mg/mL, 30 minutes at room temperature), washedBoth formalin- and methyl Carnoys-fixed, paraffin-
embedded tissue sections were deparaffinized, rehydrated, in 2 3 SSC (2 3 2 min), followed by three high stringency
washes in 0.1 3 SSC/0.1% Tween 20 (Sigma) at 558Cand then incubated in 3% hydrogen peroxide to block
endogenous peroxidases. For antibodies requiring anti- and several 2 3 SSC washes, dehydrated, and air dried.
The slides hybridized with the 35S-labeled probe weregen retrieval (Table 1), the tissue sections were immersed
in Antigen Retrieval Solution (Vector Laboratories, Bur- dipped in NTB2 nuclear emulsion (Kodak, Rochester,
NY, USA) and exposed in the dark at 48C for three to 10lingame, CA, USA) that had been preheated to 958C
and then heated for 30 minutes in a household vegetable days. After developing, the sections were counterstained
with hematoxylin and eosin and were dehydrated,steamer. Following steam heating, the slides were allowed
to cool for 20 minutes at room temperature and were mounted, and viewed. Positive cellular labeling was de-
washed in phosphate-buffered saline (PBS). The sections fined as five or more silver grains concentrated over a
were then incubated sequentially with 10% normal se- single cell.
rum (only used for polyclonal antibodies to block nonspe- Negative controls included hybridization performed
cific binding), primary antibody, biotinylated secondary on replicate tissue sections using the sense riboprobe.
antibody (Vector Laboratories), and the avidin-biotin-
Combined immunohistochemistry andhorseradish peroxidase (HRP) complex (ABC; Vector).
in situ hybridizationThe immunohistochemical signal was then visualized
with 3,39-diaminobenzidine (Sigma, St. Louis, MO, USA) Slides were first hybridized and washed as discussed
with nickel chloride enhancement to give a black-brown earlier in this article. Following the in situ hybridization
reaction product. After methyl green counterstaining, stringency washes, the slides were incubated with pri-
the slides were dehydrated and coverslipped. For all mary antibody (PGM1 HAM56, AE1/AE3, or 1A4) for
samples, negative controls for the immunohistochemis- one hour at room temperature. After washing, the slides
try included substitution of the primary with antibody were incubated with HRP-conjugated secondary anti-
an irrelevant IgG from the same species (Dako). body, and then DAB without nickel chloride enhance-
ment was used to produce a brown reaction product.
In situ hybridization Following immunostaining, the slides were washed, de-
Human osteopontin cDNA in plasmid pBluescript hydrated, and then dipped in NTB-2 emulsion.
SK(2) (plasmid OP-10) was obtained from Dr. Larry
Fisher (National Institutes of Health) [39]. It contains a
RESULTS1493 bp fragment of the human osteopontin gene, which
A total of 22 biopsies containing crescentic glomeruliincludes the entire protein-encoding sequence of the hu-
were studied by immunocytochemistry and in situ hy-man osteopontin Ia gene. The plasmid was linearized
bridization. This included 19 cases of segmentally necro-with Xba 1 and Xho 1 and then transcribed into both
tizing and crescentic glomerulonephritis of nonimmuneantisense and sense (negative control) riboprobes using
complex type, two cases of IgA nephropathy with cres-reagents from Promega (Madison, WI, USA), except
cents, and one case of diffuse proliferative lupus glomer-35S UTP, which was obtained from NEN (Boston, MA,
ulonephritis. An additional six cases of crescentic glo-USA). The details of this procedure have been pre-
merulonephritis, which had been fixed in methyl Carnoysviously published [40]. Needle biopsy kidney tissue,
solution, were studied by immunohistochemistry. Therewhich had been fixed in 10% formalin and embedded in
was a total of 110 crescentic glomeruli present, whichparaffin, was deparaffinized following standard protocol.
were primarily cellular (N 5 43) and fibrocellular (N 5The sections were washed with 0.5 3 standard saline
67) in composition (Table 2). Crescentic glomeruli werecitrate (SSC; 1 3 SSC 5 150 mmol/L NaCl, 15 mmol/L
Na citrate, pH 7.0) and digested with 10 mg/mL proteinase sorted based on their morphologic appearance in a rou-
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Table 2. Number of osteopontin mRNA expression cells aND CD68 positive monocyte/macrophages by glomerular lesion type. The numbers
shown represent the average number of positive cells per glomerulus (total number of positive cells/number of glomeruli) seen in single
label in situ hybridization and immunohistochemistry slides
Cellular crescent Fibrocellular crescent Sclerotic glomeruli
Case Diagnosis N Opn ISH1 CD681 N Opn ISH1 CD681 N Opn ISH1 CD681
1 cGN 3 8.7 13.3 0 NA NA 3 0 0
2 cGN 2 3 3.5 1 10 NP 2 0 0.5
3 cGN 1 3 3 0 NA NA 11 0.8 0
4 cGN 2 10 —a 0 NA —a 0 NA —a
5 cGN 0 NA NA 3 4 —a 0 NA NA
6 cGN 1 12 —a 4 10.5 —a 0 NA NA
7 cGN 6 11 3.5 4 3.75 3 3 0 0
8 cGN 1 9 6 5 9.2 10.6 0 NA NA
9 cGN 3 9 6 3 10.3 2 0 NA NA
10 cGN 0 NA NA 3 5 —a 0 NA NA
11 cGN 1 5.5 ND 2 3 ND 3 0 ND
12 cGN 0 NA NA 2 7 ND 2 0 NA
13 cGN 2 7 ND 1 8 ND 0 NA NA
14 cGN 3 3 6.3 10 9.3 7.5 0 NA NA
15 cGN 1 4 ND 2 3.5 ND 0 NA NA
16 cGN 0 NA NA 2 6 ND 0 NA NA
17 cGN/ANCA 4 14.5 10 6 11 12.8 0 NA NA
18 cGN/ANCA 0 NA NA 2 7 ND 0 NA NA
19 cGN/lupus 1 6 13 1 29 4 2 0 0
20 IgA, cresc. 0 NA NA 1 2 ND 0 NA ND
21 IgA, cresc. 1 2 ND 1 4 ND 0 NA NA
22 DPLGN 1 4 ND 2 6.5 ND 0 NA NA
Abbreviations used: ISH, in situ hybridization; cGN, crescentic glomerulonephritis; NA, not applicable; ND, not done; NP, not present; ANCA, anti-nuclear cell
antigen positive; IgA, cresc., IgA nephropathy with crescents; DPLGN, diffuse proliferative lupus glomerulonephritis.
a Immunohistochemistry done, results too weak to count positive cells
tine hematoxylin and eosin stain; cellular crescents ap- the crescent (Figs. 1B, 2B, and 3 C, D). Localization of
osteopontin protein by immunocytochemistry in repli-peared to be composed of organized layers of cells,
cate sections demonstrated a similar pattern of expres-whereas fibrocellular crescents were composed of a mix-
sion (Fig. 1A, 2A, and 3A) with both weak to moderateture of cells and extracellular matrix.
expression in the crescent and strong expression by indi-
Glomerular osteopontin expression vidual cells. Using combined immunohistochemistry and
in situ hybridization, osteopontin protein and mRNAAll of the tissues, both methyl Carnoys and formalin
were localized to the same cells present in the crescenticfixed, were utilized for immunohistochemistry. Addi-
glomeruli (data not shown). Morphologically normal ap-tionally, all of the formalin-fixed specimens were used for
pearing glomeruli within the same biopsies generally didin situ hybridization to demonstrate osteopontin mRNA
not contain osteopontin expressing cells, although anexpression. A majority of the crescentic glomeruli were
occasional circulating cell could be seen within the glo-shown to express osteopontin protein by immunocyto-
merular tuft or closely opposed to Bowman’s capsule,chemistry. This expression was usually localized to indi-
which did express osteopontin mRNA (Fig. 4 A, C, D)vidual cells within the crescent, as well as to cells within
or protein (Fig. 5 A, B). Occasional osteopontin mRNA
the glomerular tuft (Fig. 1A). Rarely, a strong, more expressing cells could also be seen in periglomerular
diffuse extracellular pattern of expression could be seen inflammatory infiltrates (Fig. 4 C, D). Tubular expression
distributed over the crescentic lesion (Fig. 2A). The most of osteopontin mRNA and protein was widespread (Figs.
common pattern of expression seen is shown in Figure 1–6) and was expressed by both proximal and distal tu-
3A, with individual cells expressing a high level of osteo- bules. Glomeruli of the nondiseased adult kidney, dis-
pontin protein, as well as moderate expression spread eased kidneys without crescent formation, and kidneys
throughout the crescent. In the noncrescentic control undergoing transplant rejection did not contain any os-
tissues, there was no osteopontin protein localized to teopontin-positive cells demonstrated by either in situ
glomeruli (data not shown). hybridization or immunocytochemistry, although tubu-
As can be seen in Table 2, all of the crescentic glomer- lar expression remained widespread.
uli contained cells that expressed osteopontin mRNA.
Phenotype of osteopontin-expressing cellsIn many cases, there were distinct osteopontin mRNA-
positive cells within the residual glomerular tuft as well Cellular crescents are known to contain several differ-
ent cell types, including glomerular epithelial cells, mac-as a weak, more diffuse hybridization signal spread over
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Fig. 1. Osteopontin expression in a cellular crescent. (A) Immunohisto-
chemistry with antiosteopontin antibody, LF7, demonstrating individual
strongly positive cells within the crescent and glomerular tuft (arrows),
as well as a more diffuse, weak staining within the crescent. There
is widespread tubular expression of osteopontin protein. (B) In situ
hybridization using osteopontin antisense riboprobe in a replicate tissue
section demonstrates osteopontin mRNA expression localized to indi-
vidual cells within the crescent and the glomerular tuft (arrows). Strong
hybridization signal can also be seen in a neighboring tubule.
rophages, lymphocytes. As the crescent progresses to
a more fibrous state, fibroblasts or myofibroblasts may
infiltrate from the interstitium. Because osteopontin
mRNA signal localized to cells within both the crescent
Fig. 2. Osteopontin expression in a cellular crescent. (A) Immunohisto-and the glomerular tuft, we sought to identify these cells.
chemistry demonstrates osteopontin protein localized in a strong, dif-To determine the cell type present within the crescentic
fuse pattern within the crescent. (B) In situ hybridization in a replicate
glomeruli that expressed osteopontin, tissue sections were tissue section demonstrates osteopontin mRNA expression localized
primarily to cells within the glomerular tuft. (C) Negative control in situimmunostained with antibodies directed against osteo-
hybridization using the sense osteopontin riboprobe in a replicate tissuepontin, a-smooth muscle actin, monocytes/macrophages
section, demonstrating the specificity of the hybridization procedure.
(CD68 and Ham56), T cells (CD3), vascular cell adhe-
sion molecule (VCAM; CD106), p27 and Wilms tumor
antigen (WT-1), and also hybridized with the osteopontin
was parietal epithelial cells, which normally express theseriboprobe. All of the crescentic glomeruli contained a
markers. In some of the fibrocellular crescents, a-smoothsignificant number of CD68-positive macrophages (2-30
muscle actin-expressing myofibroblasts could also beCD681 macrophages/crescentic glomerulus, median 5
identified (data not shown). The expression of WT-18.9; Table 2). The expression of CD3-positive T cells was
and p27, markers of mature visceral epithelial cells, wasless frequent (0 to 3 per crescentic glomerulus). Many
largely absent in the crescents. As can be seen in Figurescrescents also contained cytokeratin-expressing cells
3 and 4, the cell-specific pattern of osteopontin expres-(Fig. 6 E, F) and VCAM-expressing cells (data not shown),
indicating that a major component of these crescents sion appeared to match that of the macrophage marker
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Fig. 3. Osteopontin expression and macrophage localization in a cellular crescent. (A) Immunohistochemistry demonstrates osteopontin protein
strongly expressed by individual cells within the glomerular tuft and moderate, diffuse expression within the crescent. (B) In a replicate section,
CD68-positive macrophages are localized both within the glomerular tuft and the crescent. (C and D) Low- and high-power views of osteopontin
in situ hybridization in a replicate section demonstrates strong mRNA expression by individual cells within the glomerular tuft and the crescent,
as well as weak hybridization signal spread over the crescent.
CD68 closely. Because of the complexity of composition DISCUSSION
of the cellular and fibrocellular crescentic lesions, it was In this study, we retrospectively examined 25 cases of
impossible to positively identify the cells that express crescentic glomerulonephritis, 2 cases of IgA nephropa-
osteopontin using serially sectioned slides. thy with crescents, and 1 case of diffuse proliferative
Therefore, to more accurately identify the cells within lupus glomerulonephritis with crescents for the presence
the crescent, which express osteopontin, combined im- of osteopontin. In all of the cases studied, there was
munohistochemistry and in situ hybridization were per- significant expression of osteopontin protein and mRNA
formed on a subset of the biopsies. As can be seen in within the crescentic and segmentally sclerotic glomeruli,
Figure 6 A–D, the majority of cells that demonstrated as well as rare expression within histologically normal-
strong hybridization signal with the osteopontin ribo- appearing glomeruli. In noncrescentic control biopsies,
probe were monocytes/macrophages, as demonstrated no osteopontin expression could be identified in glomer-
by their colabeling with both the Ham56 and CD68 anti- uli. This finding is in agreement with previously pub-
bodies. Interestingly, monocytes and macrophages pres- lished results [25], in which we found osteopontin ex-
ent in the tubulointerstitium (Fig. 6 G, H) did not appear pressed only in tubular epithelium of mature adult kidney.
to be positive for osteopontin mRNA expression. Al- Osteopontin protein and mRNA expression demon-
though not every cell that showed positive osteopontin strated a similar pattern of expression, with both weak
hybridization signal could be definitively identified as a to moderate expression spread throughout the crescent
macrophage, none of the osteopontin mRNA-positive and very strong expression by individual cells. Rarely,
cells were colabeled with AE1/AE3 (anticytokeratin; immunohistochemistry demonstrated strong osteopon-
Fig. 5 E, F), anti–a-smooth muscle actin (data not tin protein expression throughout the crescent, as shown
shown), or anti-CD3 (data not shown), that might indi- in Figure 2. In this case, however, osteopontin mRNA
cate cells of epithelial, myofibroblast, or lymphocyte ori- expression was limited to individual cells present in the
glomerular tuft, suggesting that the osteopontin proteingin, respectively.
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Fig. 4. Osteopontin mRNA expression in normal-appearing glomeruli within crescentic glomerulonephritis (GN) biopsies coincides with macro-
phage localization. (A) In situ hybridization demonstrates osteopontin mRNA-expressing cells localized to the glomerular tuft and closely opposed
to Bowman’s capsule (arrows) within in a glomerulus uninvolved by an established crescent. (B) Immunohistochemistry in a replicate tissue section
demonstrates CD68-positive macrophages localized in a similar pattern to that shown in A (arrows). (C and D) Low- and high-power view of in
situ hybridization for osteopontin. Strong hybridization signal can be seen in tubular epithelial cells (T) surrounding a normal appearing glomerulus
within a crescentic GN biopsy. Osteopontin mRNA-expressing cells (arrows) can be seen closely opposed to Bowman’s capsule (defined by
arrowheads), in a periglomerular inflammatory infiltrate, and rarely within the glomerular tuft. (E and F ) Low- and high-power view of replicate
tissue to that shown in C and D, which has been immunostained with anti-CD68 antibody. CD68-positive macrophages (arrows) can be seen in
the urinary space, closely opposed to Bowman’s capsule and in a periglomerular infiltrate.
was secreted by these cells and may have been bound localized to individual cells present in the crescent, or it
could represent a very low level of osteopontin mRNAto cells or extracellular matrix present in the crescent.
The generally weak hybridization signal seen spread dif- expression in a number of cells present in the crescents.
The majority of the osteopontin-expressing cells pres-fusely in the crescents by in situ hybridization with the
osteopontin riboprobe is difficult to interpret. It may be ent within the glomeruli in the crescentic biopsies are
monocyte/macrophages, as identified by immunostainingbackground due to the very strong hybridization signal
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of replicate tissue sections and by combined in situ hy-
bridization and immunohistochemistry. None of the os-
teopontin mRNA-positive cells could be identified as T
cells, cytokeratin expressing epithelial cells or a-smooth
muscle actin positive myofibroblasts. However, because
of sensitivity limitations associated with the combined
immunohistochemistry and in situ hybridization tech-
nique, we cannot exclude the possibility that osteopontin
mRNA is expressed, perhaps at a lower level, by other
cell types present in the crescent.
These results are in contrast to those reported recently
in a rodent model of anti-GBM crescentic glomerulone-
phritis [20, 21]. In this rat model, osteopontin expression
appeared to localize predominantly to intrinsic renal epi-
thelial cells and preceded the influx of macrophages.
Although the biopsies of human crescentic glomerulo-
nephritis (GN) undoubtedly represent a more chronic
stage of disease than that examined in the rodent model,
within each biopsy, glomeruli could be seen that repre-
sented different stages of crescent formation. Even in
very small, cellular crescents composed of two to three
layers of cells, CD68-positive monocyte/macrophages
were present, and it was these cells in which osteopontin
expression could be detected. Additionally, in a number
of cases with features of crescentic glomerulonephritis,
histologically normal-appearing glomeruli demonstrated
rare osteopontin-producing cells closely opposed to Bow-
man’s capsule, which were shown, upon double labeling
and in replicate tissue sections, to be CD68-positive mac-
rophages. These may represent the very earliest stage of
crescent formation. There was no significant difference in
the average number of osteopontin-positive cells be-
tween cellular and fibrocellular crescents (Table 2). The
total number of osteopontin mRNA expressing cells ap-
peared rather to vary from one individual to another
and not between different crescents within the same indi-
vidual. Globally sclerotic glomeruli, which were gener-
ally devoid of cells, did not demonstrate significant osteo-
Fig. 5. Osteopontin protein expression in normal-appearing glomeru- pontin mRNA or protein.lus within a crescentic GN biopsy. (A and B) Low- and high-power view
Crescentic glomerulonephritis is an inflammatory glo-of immunohistochemistry with LF7 antibody demonstrates osteopontin
protein expression in a normal-appearing glomerulus from a biopsy of merular disease that is mediated by the immune system
crescentic GN. Osteopontin-positive cells can be seen in a small cluster
and demonstrates many of the pathologic features ofwithin the urinary space, closely opposed to Bowman’s capsule (arrow)
and in surrounding tubular epithelium. (C) High-power view of a repli- delayed-type hypersensitivity (DTH) [41, 42]. Over the
cate tissue section immunostained with anti-CD68 antibody. The same past several years, it has been shown in experimental
cluster of cells seen in A and B is shown to be CD68-positive macrophages.
c
Fig. 6. Combined immunohistochemistry and in situ hybridization. (A and B) Low- and high-power view of a crescentic glomerulus immunostained
with anti-CD68 antibody (DAB appears as a green-brown color) and hybridized with osteopontin antisense riboprobe. There are several CD68-
positive monocyte/macrophages that also demonstrate osteopontin mRNA expression (silver grains) localized within the crescent (arrows). (C and D)
Low- and high-power view of same glomerulus shown in A and B, immunostained with HAM56 antibody and hybridized with osteopontin antisense
riboprobe. A positive osteopontin hybridization signal can be seen in a monocyte/macrophage closely opposed to Bowman’s capsule (arrow). An
osteopontin positive tubule (T) can be seen in lower right corner. (E and F) Low- and high-power view of same glomerulus shown in A–D,
immunostained with anticytokeratin antibody and hybridized with osteopontin antisense riboprobe. The arrow indicates the same osteopontin
mRNA-positive cell shown in C and D. None of the cytokeratin-positive cells (brown) within the crescent hybridized with the osteopontin riboprobe.
The tubular epithelium (T) shown in the lower right of the photograph demonstrates colocalization of cytokeratin protein and osteopontin mRNA.
(G and H) High-power view of tubulointerstitium from the same biopsy shown in A–F. The sections were immunostained with HAM56 (G) or
CD68 (H) antibody and hybridized with the osteopontin antisense riboprobe. Osteopontin-positive tubules (T) can be seen, as well as monocyte/
macrophages (arrows), which do not express osteopontin mRNA.
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models of crescentic GN that CD41 T cells are essential signaling pathway to contribute to the pathogenesis of
the crescentic lesion further.for the development of crescents. This has been demon-
In this study, we have examined a series of humanstrated both in depletion studies using monoclonal anti-
crescentic GN biopsies for the expression of osteopontin.bodies [43] and in mice genetically deficient in CD41 T
In all of the cases studied, there was significant expres-cells [44]. The glomerular accumulation of DTH media-
sion of osteopontin within the crescentic glomeruli. Nonetors, namely CD41 T cells and macrophages, has been
of the control tissues demonstrated osteopontin expres-well documented in human crescentic GN [45–48]. It is
sion within glomeruli. Using combined in situ hybridiza-unknown which factors may induce osteopontin expres-
tion and immunocytochemistry, we show that it is pri-sion in macrophages within crescentic lesions. Monocytic
marily macrophages and not intrinsic renal cells that arecell lines in vitro have been shown to up-regulate osteo-
producing high levels of osteopontin within the cres-pontin expression in response to various cytokines, in-
centic glomeruli. Because of its properties as a chemotac-cluding interleukin-1 [49] and tumor necrosis factor-a
tic agent and modulator of the NF-kB signaling pathway,[50]. This study is the first to report that the macrophages
osteopontin may be a potential target of intervention inthat participate in the human glomerular crescentic le-
human crescentic GN.sion appear to represent some subclass of activated mac-
rophage, which is phenotypically distinct from the inter-
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